Consolidated Statements of Cash Flow (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net (Loss)	$ (3,361,264)	$ (1,371,637)
Adjustments to reconcile Net (Loss) to Net Cash provided by operations:
Depreciation and amortization	203,872	73,792
Stock Grants	269,661
Stock for Services	22,350	62,500
Employee stock awards	482,625
Changes in Current Assets and Liabilities
Accounts receivable	140,706	(252,158)
Allowance for doubtful accounts	(6,000)
Due to (from) related parties	(4,104)	29,253
Inventories	(973,399)	(114,521)
Prepaid expenses	(80,679)	182,217
Deposits	(132,163)
Accounts payable	78,379	83,713
Accrued liabilities	(138,557)	39,896
Net cash used in operating activities	(3,248,573)	(1,266,944)
Cash flows from investing activities
Purchase of equipment	(1,157,915)	(4,170)
Acquisition Deposit	(250,000)
Net cash used in investing activities	(1,407,915)	(4,170)
Cash flow from financing activities
Convertible note payment		(100,000)
Note payment - related party		(373,000)
Insurance premium note payment	(71,998)	(60,967)
Sale of common stock	3,247,030	1,746,875
Common stock issued for exercised warrants	4,767,625
Organizational and fundraising costs	(719,974)
Net cash provided by financing activities	7,222,683	1,212,908
Net increase in cash	2,316,195	(58,206)
Cash, beginning of period	4,381,643	100,135
Cash, end of period	6,697,838	41,929
Supplemental cash flow disclosures
Cash paid during the period for Interest	2,903	6,545
Cash paid during the period for Income taxes
Non-cash investing and financing activities:
Additional paid-in-capital	(11)
Common Stock	11
Prepaid interest		(46,188)
Additional paid-in-capital		46,188
Prepaid legal services		(224,000)
Issuance of common stock		224,000
Notes payable - related parties		200,000
Issuance of common stock		750,000
Patent acquisitions		(950,000)
Total non-cash investing and financing activities